Search for appropriate treatment strategy using fulvestrant for postmenopausal ER-positive advanced or recurrent breast cancer patients in Japan (JBCRG-C06; Safari)

被引：0

作者：

Kawaguchi, H. ^{[1
,11
]}

Masuda, N. ^{[2
]}

Nakayama, T. ^{[3
]}

Aogi, K. ^{[4
]}

Anan, K. ^{[5
]}

Ito, Y. ^{[6
]}

Ohtani, S. ^{[7
]}

Sato, N. ^{[8
]}

Saji, S. ^{[9
]}

Tokunaga, E. ^{[10
]}

Nakamura, S.

Hasegawa, Y. ^{[12
]}

Hattori, M. ^{[13
]}

Fujisawa, T. ^{[14
]}

Morita, S. ^{[15
]}

Yamaguchi, M. ^{[16
]}

Yamashita, T. ^{[17
]}

Yamamoto, Y. ^{[18
]}

Ohno, S. ^{[19
]}

Toi, M. ^{[20
]}

机构：

[1] Matsuyama Red Cross Hosp, Breast Surg, Matsuyama, Ehime, Japan

[2] Osaka Natl Hosp, Dept Surg Breast Oncol, Osaka, Japan

[3] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Breast & Endocrine Surg, Osaka, Japan

[4] Shikoku Canc Ctr, Dept Breast Oncol, Matsuyama, Ehime, Japan

[5] Kitakyushu Municipal Med Ctr, Dept Surg, Kitakyushu, Fukuoka, Japan

[6] Canc Inst Hosp JFCR, Breast Med Oncol Dept, Tokyo, Japan

[7] Hiroshima City Hiroshima Citizens Hosp, Dept Breast Surg Hiroshima, Hiroshima, Japan

[8] Niigata Canc Ctr Hosp, Dept Breast Oncol, Niigata, Japan

[9] Fukushima Med Univ, Dept Med Oncol, Fukushima, Japan

[10] Kyushu Canc Ctr, Dept Breast Oncol, Fukuoka, Japan

[11] Showa Univ, Sch Med, Showa Univ Hosp, Dept Surg,Div Breast Surg Oncol, Tokyo 142, Japan

[12] Hirosaki Municipal Hosp, Dept Breast Surg, Hirosaki, Aomori, Japan

[13] Aichi Canc Ctr Hosp, Dept Breast Oncol, Nagoya, Aichi 464, Japan

[14] Gunma Prefectural Canc Ctr, Dept Breast Oncol, Ohta, Gunma, Japan

[15] Kyoto Univ, Dept Biomed Stat & Bioinformat, Grad Sch Med, Kyoto, Japan

[16] JCHO Kurume Gen Hosp, Dept Breast Surg, Kurume, Fukuoka, Japan

[17] Komagome Hosp, Dept Breast Surg, Tokyo Metropolitan Canc & Infect Dis Ctr, Tokyo, Japan

[18] Kumamoto Univ, Grad Sch Med Sci, Dept Breast & Endocrine Surg, Kumamoto, Japan

[19] Canc Inst Hosp JFCR, Breast Oncol Ctr, Tokyo, Japan

[20] Kyoto Univ, Dept Breast Surg, Grad Sch Med, Kyoto, Japan

来源：

EUROPEAN JOURNAL OF CANCER | 2016年 / 57卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

379

引用

页码：S109 / S109

页数：1

共 48 条

[1] Outcomes of fulvestrant therapy among Japanese women with ER-positive HER2-positive advanced or metastatic breast cancer: A subgroup analysis of the JBCRG-C06 safari study
Hagi, Misato
Kawaguchi, Hidetoshi
Masuda, Norikazu
Saji, Shigehira
Yamamoto, Yutaka
Nakayama, Takahiro
Aogi, Kenjiro
Anan, Keisei
Ito, Yoshinori
Ohtani, Shoichiro
Sato, Nobuaki
Takano, Toshimi
Tokunaga, Eriko
Nakamura, Seigo
Hasegawa, Yoshie
Hattori, Masaya
Fujisawa, Tomomi
Yamaguchi, Miki
Yamashita, Hiroko
Yamashita, Toshinari
Yotsumoto, Daisuke
Morita, Satoshi
Toi, Masakazu
Ohno, Shinji
CANCER RESEARCH, 2020, 80 (04)
[2] Retrospective study using database for the effectiveness of medroxyprogesterone acetate in patients with ER-positive/HER2-negative postmenopausal advanced breast cancer: An additional analysis of the JBCRG-C06 Safari study
Utsunomiya, Kaho
Kawaguchi, Hidetoshi
Yamamoto, Yutaka
Saji, Shigehira
Masuda, Norikazu
Nakayama, Takahiro
Aogi, Kenjiro
Anan, Keisei
Ohtani, Shoichiro
Sato, Nobuaki
Takano, Toshimi
Tokunaga, Eriko
Nakamura, Seigo
Hasegawa, Yoshie
Hattori, Masaya
Fujisawa, Tomomi
Morita, Satoshi
Yamaguchi, Miki
Yamashita, Toshinari
Yotsumoto, Daisuke
Toi, Masakazu
Ohno, Shinji
CANCER RESEARCH, 2023, 83 (05)
[3] Fulvestrant with or without anti-HER2 therapy in patients in a postmenopausal hormonal state and with ER-positive HER2-positive advanced or metastatic breast cancer: A subgroup analysis of data from the Safari study (JBCRG-C06)
Masuyama, Misato
Masuda, Norikazu
Kawaguchi, Hidetoshi
Yamamoto, Yutaka
Saji, Shigehira
Nakayama, Takahiro
Aogi, Kenjiro
Anan, Keisei
Ohtani, Shoichiro
Sato, Nobuaki
Takano, Toshimi
Tokunaga, Eriko
Nakamura, Seigo
Hasegawa, Yoshie
Hattori, Masaya
Fujisawa, Tomomi
Morita, Satoshi
Yamaguchi, Miki
Yamashita, Toshinari
Yotsumoto, Daisuke
Toi, Masakazu
Ohno, Shinji
CANCER MEDICINE, 2023, 12 (17): : 17718 - 17730
[4] Outcomes of fulvestrant therapy among japanese women with advanced breast cancer: a retrospective multicenter cohort study (JBCRG-C06; Safari)
H. Kawaguchi
N. Masuda
T. Nakayama
K. Aogi
K. Anan
Y. Ito
S. Ohtani
N. Sato
S. Saji
E. Tokunaga
S. Nakamura
Y. Hasegawa
M. Hattori
T. Fujisawa
S. Morita
M. Yamaguchi
T. Yamashita
Y. Yamamoto
S. Ohno
M. Toi
Breast Cancer Research and Treatment, 2017, 163 : 545 - 554
[5] Factors associated with overall survival after recurrence in patients with ER-positive/HER2-negative postmenopausal breast cancer: an ad hoc analysis of the JBCRG-C06 Safari study
Kawaguchi, Hidetoshi
Yamamoto, Yutaka
Saji, Shigehira
Masuda, Norikazu
Nakayama, Takahiro
Aogi, Kenjiro
Anan, Keisei
Ito, Yoshinori
Ohtani, Shoichiro
Sato, Nobuaki
Takano, Toshimi
Tokunaga, Eriko
Nakamura, Seigo
Hasegawa, Yoshie
Hattori, Masaya
Fujisawa, Tomomi
Morita, Satoshi
Yamaguchi, Miki
Yamashita, Hiroko
Yamashita, Toshinari
Yotsumoto, Daisuke
Toi, Masakazu
Ohno, Shinji
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2022, 52 (06) : 545 - 553
[6] Factors associated with prolonged time to treatment failure with fulvestrant 500mg in patients with postmenopausal estrogen receptor-positive advanced/metastatic breast cancer (JBCRG-C06; Safari): A subgroup analysis
Kawaguchi, H.
Aogi, K.
Masuda, N.
Nakayama, T.
Ito, Y.
Ohtani, S.
Sato, N.
Takano, T.
Saji, S.
Tokunaga, E.
Hasegawa, Y.
Hattori, M.
Fujisawa, T.
Morita, S.
Yamashita, H.
Yamashita, T.
Yamamoto, Y.
Yotsumoto, D.
Toi, M.
Ohno, S.
ANNALS OF ONCOLOGY, 2017, 28
[7] Outcomes of fulvestrant therapy among japanese women with advanced breast cancer: a retrospective multicenter cohort study (JBCRG-C06; Safari)
Kawaguchi, H.
Masuda, N.
Nakayama, T.
Aogi, K.
Anan, K.
Ito, Y.
Ohtani, S.
Sato, N.
Saji, S.
Tokunaga, E.
Nakamura, S.
Hasegawa, Y.
Hattori, M.
Fujisawa, T.
Morita, S.
Yamaguchi, M.
Yamashita, T.
Yamamoto, Y.
Ohno, S.
Toi, M.
BREAST CANCER RESEARCH AND TREATMENT, 2017, 163 (03) : 545 - 554
[8] Retrospective study on the effectiveness of medroxyprogesterone acetate in the treatment of ER-positive/HER2-negative post-menopausal advanced breast cancer: an additional analysis of the JBCRG-C06 Safari study
Kawaguchi, Hidetoshi
Yamamoto, Yutaka
Saji, Shigehira
Masuda, Norikazu
Nakayama, Takahiro
Aogi, Kenjiro
Anan, Keisei
Ohtani, Shoichiro
Sato, Nobuaki
Takano, Toshimi
Tokunaga, Eriko
Nakamura, Seigo
Hasegawa, Yoshie
Hattori, Masaya
Fujisawa, Tomomi
Morita, Satoshi
Yamaguchi, Miki
Yamashita, Toshinari
Yotsumoto, Daisuke
Toi, Masakazu
Ohno, Shinji
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2023, 53 (03) : 203 - 211
[9] Factors associated with prolonged time to treatment failure with fulvestrant 500 mg in patients with post-menopausal estrogen receptor-positive advanced breast cancer: a sub-group analysis of the JBCRG-C06 Safari study
Kawaguchi, Hidetoshi
Masuda, Norikazu
Nakayama, Takahiro
Aogi, Kenjiro
Anan, Keisei
Ito, Yoshinori
Ohtani, Shoichiro
Sato, Nobuaki
Saji, Shigehira
Takano, Toshimi
Tokunaga, Eriko
Nakamura, Seigo
Hasegawa, Yoshie
Hattori, Masaya
Fujisawa, Tomomi
Morita, Satoshi
Yamaguchi, Miki
Yamashita, Hiroko
Yamashita, Toshinari
Yamamoto, Yutaka
Yotsumoto, Daisuke
Toi, Masakazu
Ohno, Shinji
CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (01) : 49 - 54
[10] Factors associated with prolonged overall survival in patients with postmenopausal estrogen receptor-positive advanced breast cancer using real-world data: a follow-up analysis of the JBCRG-C06 Safari study
Kawaguchi, Hidetoshi
Masuda, Norikazu
Nakayama, Takahiro
Aogi, Kenjiro
Anan, Keisei
Ito, Yoshinori
Ohtani, Shoichiro
Sato, Nobuaki
Saji, Shigehira
Takano, Toshimi
Tokunaga, Eriko
Nakamura, Seigo
Hasegawa, Yoshie
Hattori, Masaya
Fujisawa, Tomomi
Morita, Satoshi
Yamaguchi, Miki
Yamashita, Hiroko
Yamashita, Toshinari
Yamamoto, Yutaka
Yotsumoto, Daisuke
Toi, Masakazu
Ohno, Shinji
BREAST CANCER, 2020, 27 (03) : 389 - 398

← 1 2 3 4 5 →